Aspire-lakewood Holdings, Inc. income statement
In fiscal 2025, Aspire-lakewood Holdings, Inc. reported revenue of $6,202, operating income of −$19.4m (a -312016.9% margin) and net income of −$24.5m, or −$16.38 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of revenue | 0 | 0 |
| Gross profit | −0 | −0 |
| Research and development | 1 | 1 |
| Selling and marketing | 1 | 2 |
| General and administrative | 18 | 4 |
| Operating income | −19 | −7 |
| Interest expense | 9 | 9 |
| Income before tax | −24 | — |
| Net income | −24 | −11 |
| Diluted EPS | −$16.38 | — |
| Diluted shares (average) | 1m | — |
| Quarter | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|
| Revenue | 2 | 4 | 28 | 63 |
| Cost of revenue | 1 | 5 | 23 | 51 |
| Gross profit | 1 | −1 | 6 | −30 |
| Research and development | 208 | 100 | 297 | 233 |
| Selling and marketing | 425 | 93 | 335 | 1,215 |
| General and administrative | 513 | 1,655 | 1,020 | 970 |
| Operating income | −1,145 | −1,849 | −1,646 | −2,678 |
| Interest expense | 1,480 | 6,233 | 1,595 | 0 |
| Income before tax | — | — | −3,223 | −1,268 |
| Net income | −1,850 | −4,708 | −3,223 | −1,268 |
| Diluted EPS | −$0.04 | −$15.95 | −$20.57 | −$1.22 |
Compare with peers
- Akanda Corp. income statement
- PRF Technologies Ltd. income statement
- Scienture Holdings, Inc. income statement
- 60 Degrees Pharmaceuticals, Inc. income statement
- China SXT Pharmaceuticals, Inc. income statement
Head to head: AKAN vs ASBPASBP vs PRFXASBP vs SCNX
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies